Malignant pleural mesothelioma is an aggressive malignancy of the pleural surface,
predominantly caused by prior asbestos exposure. There is a global epidemic of malignant …

Malignant pleural effusions (MPE) are a common pathology, treated by respiratory
physicians and thoracic surgeons alike. In recent years, several well-designed randomized …

There are substantial differences in international guidelines for the management of
pneumothorax and much geographical variation in clinical practice. These discrepancies …

Background Malignant pleural effusion (MPE) causes debilitating breathlessness and
predicting survival is challenging. This study aimed to obtain contemporary data on survival …

Background: This Guideline, a collaborative effort from the American Thoracic Society,
Society of Thoracic Surgeons, and Society of Thoracic Radiology, aims to provide evidence …

Heart failure is associated with Cheyne–Stokes breathing, which fragments patients' sleep.
Correction of respiratory disturbance may reduce sleep fragmentation and excessive …

Background: Antibiotic choices for pleural infection are uncertain as its bacteriology is poorly
described. Methods: Pleural fluid from 434 pleural infections underwent standard culture …

The European Respiratory Society (ERS)/European Society of Thoracic Surgeons
(ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for …

Background Malignant pleural effusion affects more than 750,000 persons each year across
Europe and the United States. Pleurodesis with the administration of talc in hospitalized …

We report two trials describing whether talc pleurodesis with a mean particle size of less
than 15 μm (“mixed” talc) produces more lung and systemic inflammation than tetracycline or …